companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

JOHNSON BUILDING & CONSTRUCTION

SALISBURY-USA

Company Name:
Corporate Name:
JOHNSON BUILDING & CONSTRUCTION
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 29 Dock Lane,SALISBURY,MA,USA 
ZIP Code:
Postal Code:
1952 
Telephone Number: 9784626552 (+1-978-462-6552) 
Fax Number: 9784630464 (+1-978-463-0464) 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
152130 
USA SIC Description:
Construction 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
JOHNSON LUMBER COMPANY
MOUTSOULAS FOR MAYOR CAMPAIGN
KRES; STEVEN
Next company profile:
CINEMA SERVICE AND SUPPLY
MICRION CORPORATION
D & J SPORTS










Company News:
  • Our leadership team - Johnson Johnson
    Joseph J Wolk (Joe) is the Executive Vice President and Chief Financial Officer for Johnson Johnson Joe serves as a member of the company’s Executive Committee, playing a strategic role in the overall management of the organization and leading the development and execution of the business’ global long-term financial strategy
  • Johnson Johnsons dual-targeting CAR T-cell therapy shows encouraging . . .
    Johnson Johnson (NYSE: JNJ) announced today the first clinical data from an ongoing Phase 1b study for JNJ-90014496 (JNJ-4496), an investigational dual-targeting anti-CD19 CD20 bispecific autologous chimeric antigen receptor (CAR) T-cell therapy, being studied in patients with relapsed or refractory large B-cell lymphoma (R R LBCL) who have not been previously treated with CAR T-cell therapy
  • Johnson Johnson’s dual-targeting CAR T-cell therapy shows encouraging . . .
    MILAN (June 13, 2025) – Johnson Johnson (NYSE: JNJ) announced today the first clinical data from an ongoing Phase 1b study for JNJ-90014496 (JNJ-4496), an investigational dual-targeting anti-CD19 CD20 bispecific autologous chimeric antigen receptor (CAR) T-cell therapy, being studied in patients with relapsed or refractory large B-cell lymphoma (R R LBCL) who have not been previously
  • portman. jnj. com
    WARNING NOTICE: This system is restricted solely to Johnson Johnson users for legitimate business only The actual or attempted unauthorized access, use or modification of this system is strictly prohibited by Johnson Johnson Unauthorized users are subject to Company disciplinary proceedings and or criminal and civil penalties under state, federal or other applicable domestic and foreign
  • Explore current job openings | Johnson Johnson | Johnson Johnson . . .
    Explore exciting job openings at J J Search global roles in healthcare and join a team committed to innovation, growth and a healthier future for all
  • Johnson Johnson showcases latest advancements in cancer innovation . . .
    †See the NCCN Guidelines for detailed recommendations, including other treatment options ‡ The NCCN Guidelines for NSCLC provide recommendations for certain individual biomarkers that should be tested and recommend testing techniques but do not endorse any specific commercially available biomarker assays or commercial laboratories § The NCCN Content does not constitute medical advice
  • Johnson Johnson: Changing health for humanity
    We’re building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal
  • Johnson Johnson
    WARNING NOTICE: This system is restricted solely to Johnson Johnson users for legitimate business only The actual or attempted unauthorized access, use or modification of this system is strictly prohibited by Johnson Johnson Unauthorized users are subject to Company disciplinary proceedings and or criminal and civil penalties under state, federal or other applicable domestic and foreign
  • Johnson Johnson
    Note: Your browser does not support JavaScript, Press Continue to proceed
  • Locations | Johnson Johnson Careers
    Learn about the regions and countries where J J operates and explore career opportunities, search for jobs and apply to join us wherever you are in the world




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer